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Abstract
Ceramides are sphingolipids that greatly stabilize ordered membrane domains (lipid rafts), and displace cholesterol from them. Ceramide-rich
rafts have been implicated in diverse biological processes. Because ceramide analogues have been useful for probing the biological function of
ceramide, and may have biomedical applications, it is important to characterize how ceramide structure affects membrane properties, including lipid
raft stability and composition. In this report, fluorescence quenching assays were used to evaluate the effect of analogues of ceramide with different
N-acyl chains or different sphingoid backbones on raft stability and sterol content. The effect of replacing 18 mol% of sphingomyelin (SM) with
ceramide in vesicles composed of a 1:1 (mol:mol) mixture of SM and dioleoylphosphatidylcholine (DOPC), with or without 25 mol% sterol, was
examined. In the absence of sterol, the thermal stability of the SM-rich ordered domains increased with ceramide N-acyl chain length in the order
C2:0∼C6:0∼C8:0bno ceramidebC12:0bC16:0. In vesicles containing 25 mol% cholesterol (1:1:0.66 sphingolipid:DOPC:cholesterol), the
dependence of raft stability on ceramide N-acyl chain length increased in the order C8:0~C6:0bC2:0bC12:0~no ceramidebC16:0. We also
studied the stability of lipid rafts in the presence of N-lauroyl- and N-palmitoylsphingosine analogues containing altered structures in or near the
polar portion of the sphingoid base. In almost all cases, the analogues stabilized rafts to about the same degree as a normal ceramide containing the
same acyl chain. The only exception was N-palmitoyl-4D-ribophytosphingosine, which was very strongly raft-stabilizing. We conclude that
variations in sphingoid base structure induce only insignificant changes in raft properties. N-Lauroyl and N-palmitoylsphingosine and their
analogues displaced sterol from rafts to a significant degree. Both C12:0 and C16:0 analogues of ceramide may be good mimics of natural ceramide,
and useful for cellular studies in which maintenance of the normal physical properties of ceramide are important.
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Ceramide forms the structural backbone of most sphingoli-
pids. Free ceramide is present in cell membranes and occurs in
high concentrations in the stratum corneum of the human skin.
It can be generated in vivo by ceramide synthase, by enzymatic
degradation of glucosylceramide and galactosylceramide, or by
sphingomyelinase (SMase)-catalyzed hydrolysis of sphingo-
myelin. SMases have been reported to be activated in many
pathways that regulate processes such as apoptosis [1–3], B and
T cell activation [4,5], and TNFα-mediated-signaling [6–8].⁎ Corresponding author. Tel.: +1 631 632 8564; fax: +1 631 632 8575.
E-mail address: Erwin.London@stonybrook.edu (E. London).
0005-2736/$ - see front matter © 2007 Elsevier B.V. All rights reserved.
doi:10.1016/j.bbamem.2007.05.007Ceramide is also generated by SMases upon infection by several
bacterial and viral pathogens [9–12]. Under some conditions it
has been reported that activation of SMase leads to the gene-
ration of ceramide-rich membrane domains (ceramide-rich lipid
rafts) on the plasma membrane, which can exist in the form of
large ceramide-rich platforms [10,13]. The formation and func-
tional role of ceramide-rich domains have been reviewed
recently [14].
Lipid rafts are tightly packed, ordered membrane domains
that are generally enriched in both lipids with saturated acyl
chains (e.g., sphingolipids) and sterol [15,16]. They are believed
to segregate from, and co-exist in eukaryotic membranes with,
disordered membrane domains that are rich in lipids with un-
saturated acyl chains [15]. Natural ceramide has a long saturated
2206 Megha et al. / Biochimica et Biophysica Acta 1768 (2007) 2205–2212N-acyl chain and small polar headgroup, making it a lipid with
very tight packing properties, as illustrated by the fact that model
membranes composed of ceramide have a high order-to-disorder
transition temperature [17]. Thus, it is not surprising that cera-
mide has the ability to stabilize and promote raft formation in
model membranes [18,19]. In addition, we recently observed
that both pure C18:0-ceramide and natural ceramide mixtures
have the ability to displace sterols from rafts [19]. Displacement
of sterol by ceramide has been confirmed in other studies using
both model and cellular membranes [20,21] and appears to be of
relevance for the constitutive degradation of intralysosomal
membranes [22]. Displacement of sterol could result in ceramide
having marked effects on lipid raft composition and physical
properties.
In this report, we studied how the raft-stabilizing properties
of ceramide are influenced by structural features in the ceramide
molecule. A Tempo-based fluorescent quenching assay was
used to measure the thermal stability of ordered domains in
model membrane vesicles composed of a mixture of ordered
and disordered domain forming lipids [23]. First, the influenceFig. 1. Structures of the ceramide analogues examined in this study. Names of the analo
methylheptadec-3enyl]dodecanamide, compound 2 N-[(1S,2R)-2-Hydroxy-1-(hydro
Hydroxy-1-(hydroxymethyl)-2-methylheptadec-3-enyl]dodecanamide, compound 4-N-
compound 5 (rac-(2′-tridecylcyclopropyl)-(3R)-3-hydroxy-(2S)-2-(dodecanamido)pro
mino)-(E)-pentadec-3-en-2-ol, compound 7 (2S,3R)-2-palmitoylamido-4-octadecyne-1,
diol, compound 9 (2S,3R,5R)-2-palmitoylamidooctadeca-4,5-diene-1,3-diol, compound
N-palmitoylphytosphingosine.of N-acyl chain length on ceramide-induced stabilization of
ordered domains was measured in bilayers with or without
cholesterol. Then, the raft-stabilizing abilities of a series of
synthetic ceramide analogs with various structural alterations in
or near the polar headgroup were compared (Fig. 1). In addition,
the ability of ceramide analogues to displace cholesterol from
ordered domains was measured. The raft-stabilizing and sterol-
displacing properties of many ceramide analogues were very
similar to those of natural ceramide. These observations have
important implications for the design of biomedically useful
analogues of ceramide.
2. Materials and methods
2.1. Materials
Dipalmitoylphosphatidylcholine (DPPC); porcine brain sphingomyelin
(SM); cholesterol; C2:0-, C6:0-, C8:0-, C12:0-, and C16:0-ceramides;
dioleoylphosphatidylcholine (DOPC); and 1-palmitoyl-2-(12-doxyl)-stearoyl-
phosphatidylcholine (12-SLPC) were purchased from Avanti Polar Lipids
(Alabaster, AL). Fig. 1 shows the structures of the ceramide analogues studied.gues are as follows: compound 1 N-[(1S,2R,3E)-2-Hydroxy-1-(hydroxymethyl)-2-
xymethyl)-2-methylheptadecyl]dodecanamide, compound 3 N-[(1S,2R,3Z)-2-
[(1S,2R)-2-Hydroxy-1-(hydroxymethyl)-2-methylheptadec-3-ynyl]dodecanamide,
panol), compound 6 (rac-1-(5′,5′-dimethyl-1′,3′-dioxan-2′-yl)-1-(dodecanoyla-
3-diol, compound 8 (2S,3R)-3-(3′-Dodecylphenyl)-2-palmitoylamidopropane-1,3-
10 (2S,3R)-2-palmitoylamido-(7E)-octadecene-1,3-diol, compound 11 (2S,3S,4S)-
Fig. 2. Effect of ceramides on raft stability as assessed from the effect of
temperature on quenching of Lc-TMADPH by Tempo. Vesicles were composed
of (A) 32:18:50 SM:ceramide:DOPC (mol%) and B) 19.5:18:37.5:25 SM:cera-
mide:DOPC:cholesterol. Key: C2:0 cer (open circle), C6:0 cer (open triangle),
C8:0 cer (plus sign), C12:0 (filled black circle), C16:0 cer (filled triangle), and
no ceramide (filled gray circle). “No ceramide” refers to 50:50 total SM:DOPC.
Results shown are average values from duplicates. Quenching data were fit to
sigmoidal curves using the program Slidewrite for this and the following figures
(see Table 1 for details). Samples in this and the following figures contained
50 nmol of total lipid in 1 ml of PBS).
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references [24–27]. The C3-methylceramides 1−3 were prepared as described
previously [27]. Compound 5 (rac-(2′-tridecylcyclopropyl)-(3R)-3-hydroxy-
(2S)-2-(dodecanamido)propanol) was prepared by cyclopropanation of N-
lauroyl-sphingosine according to a modification of the Simmons–Smith reaction
[28,29]; compound 6 (rac-1-(5′,5′-dimethyl-1′,3′-dioxan-2′-yl)-1-(dodecanoy-
lamino)-(E)-pentadec-3-en-2-ol; was prepared by nitro aldol addition [30] of
2,2-dimethyl-5-(nitromethyl)-1,3-dioxane to tetradecanal, followed by catalytic
hydrogenation and N-acylation (P. Sawatzki, Ph.D. Thesis, University of Bonn,
2003). Lipid purity was confirmed by TLC as described previously [31]. 2,2,6,6-
Tetramethylpiperidine-1-oxyl (Tempo) and dehydroergosterol (DHE) were
purchased from Sigma-Aldrich (St. Louis, MO). N-(22-(Diphenylhexatrienyl)
docosyl)-N,N,N-trimethylammonium iodide (long-chain TMA-DPH, Lc-
TMADPH) was a kind gift from G. Duportail and D. Heissler (Université
Louis Pasteur, Strasbourg).
2.2. Vesicle preparation
Ethanol dilution small unilamellar vesicles (SUVs) were prepared as des-
cribed previously [19]. Vesicles containing the desired lipid mixture and 0.1 mol%
Lc-TMADPH were dispersed at 70 °C in PBS (10 mM Na phosphate,
150 mM NaCl, pH 7.0) at a final lipid concentration of 50 μM, and then
cooled to room temperature. Background samples lacking Lc-TMADPH were
prepared similarly.
2.3. Tempo quenching assay to measure raft stability
To “F samples” containing SUVs of the desired lipid composition an aliquot
of a 353 mM solution of Tempo dissolved in ethanol was added. The final
Tempo concentration was 2 mM. The same volume of ethanol lacking Tempo
was added to prepare “Fo samples.” Tempo quenching of Lc-TMADPH fluo-
rescence (excitation wavelength 357 nm; emission wavelength 429 nm) was
measured on a Fluorolog 3 spectrofluorimeter (Jobin-Yvon, Edison, NJ) as a
function of temperature as described previously [23]. The ratio of fluorescence
intensity in the F sample to that in the Fo sample (F/Fo) was calculated after the
fluorescence in background samples were subtracted [32].
2.4. Displacement of sterol from ceramide-rich rafts
DHE quenching by 12-SLPC was used to monitor displacement of sterol
from rafts as described previously [19]. Briefly, ethanol dilution vesicles com-
posed of 3:3:1:1 DPPC:DOPC:cholesterol:DHE (mol:mol) (Fo samples) or
3:3:1:1 DPPC:12-SLPC:cholesterol:DHE (F samples) were prepared as
described above. 12SLPC is a fluorescence quenching lipid that behaves
similarly to DOPC [32,33]. F/Fo was calculated after subtracting the signal from
background samples containing cholesterol in place of DHE. DHE fluorescence
was measured using an excitation wavelength of 324 nm and emission
wavelength of 376 nm.
3. Results
3.1. Raft-stabilizing ability of ceramides with varying N-acyl
chain lengths
A fluorescence quenching assay employing the nitroxide-
containing Tempo molecule was used to assess raft formation
[23]. Model membrane vesicles containing a fluorescent mole-
cule and a lipid mixture that tends to form co-existing ordered
and disordered domains were prepared. The fluorescent probe
Lc-TMADPH, which partitions favorably into ordered phases,
was used [18,19,31]. Tempo binds to disordered domains much
more strongly than to ordered domains, so that the quenching of
Lc-TMADPH is weak when ordered domains are present, but
strong when the membrane is fully in a disordered state [31,34].To study ordered domain/raft stability, we measured quenching
of Lc-TMADPH fluorescence by Tempo as a function of
temperature. Ordered domains melt at a high temperature, and
on melting mix with the lipids in the disordered domains. An
ordered domain-melting temperature (Tm) can be derived from
this experiment [31,32]. The higher the Tm, the more stable the
rafts.
We first determined the effect of ceramides on the stability of
ordered domains in mixtures containing equimolar sphingolipid
and DOPC (32:18:50 SM:ceramide:DOPC (mol:mol)) (Fig.
2A). Compared with a sample lacking ceramide (50:50 SM:
DOPC), short-chain ceramides (those with a C2:0, C6:0, or
C8:0 N-acyl chain) destabilized ordered domains (Fig. 2A and
Table 1), indicating that the short-chain ceramides are less
Table 1
Tm (melting temperature) of ordered domains in vesicles containing ceramides
with various N-acyl chain lengths
Ceramide Tm (°C)
−chol +25 mol% chol
None 25.5±0.2 34.0±0.4 a
C2:0 19.1±2.8 31.7±0.3
C6:0 [9.4–21.9] [25.6–31.4]
C8:0 19.3±3.4 [23.1–31.1]
C12:0 37.6±0.5 33.4±0.7
C16:0 46.9±0.0 47.8±0.5
Data from the experiments shown in Fig. 2 were fit to a sigmoidal curve
(Slidewrite program, Advanced Graphics Software, Encinitas, CA) and then Tm
was calculated from the mid-point of the curve. The values shown are the
average values and the range from duplicate samples. For the lipid composition
of the vesicles, see the caption to Fig. 2. In the cases in which a Tm range is
shown melting curves were too incomplete to give a sigmoidal fit with a
physically meaningful limiting quenching value (i.e. F/Fob1) at low
temperature. In this case the Tm range shown (in brackets) is for the maximum
and minimum possible low temperature limiting F/Fo values. The maximum
limiting F/Fo value is 1, and the minimum F/Fo value is the experimental value
at the lowest temperature measured. The midpoint of this range may be
considered a useful approximation to the actual Tm.
a Data from reference [23].
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bility of the ordered domains was enhanced by C12:0-ceramide,
and to an even greater degree by C16:0-ceramide. Ordered
domain stability in the presence of C16:0-ceramide was similar
to that measured previously for C18:0-ceramide in a slightly
different lipid mixture [19]. This shows that longer chain
ceramides stabilize ordered domain formation.
In the above samples, ceramide replaced some of the SM, so
that the SM content was lower than in the ceramide-containing
samples. We repeated these experiments using samples in which
ceramide replaced some of the DOPC (50:18:32 SM:ceramide:
DOPC), so that the mol% SM in ceramide-containing samples
was the same as that in ceramide-lacking samples. In these
samples, the Tm values for vesicles containing C6:0- and C8:0-
ceramide were still found to be slightly lower than the Tm value
in the absence of ceramide, showing that these short-chain
ceramides have an effect on ordered domain stability that is
similar to that as DOPC (data not shown).
Canonical model membranes containing ordered domains
mimicking rafts contain cholesterol (chol); therefore, we
determined if these ceramides affected raft stability in vesicles
containing chol. Samples containing ceramide were composed
of 19.5:18:37.5:25 (mol:mol) SM:ceramide:DOPC:chol, and
those without ceramide were composed of 37.5:37.5:25 SM:
DOPC:chol. Note that ceramide forms a larger fraction of the
total sphingolipid (SM+ceramide) than in the samples lacking
sterol.
In most cases, rafts (we will use the term “raft” for ordered
domains in samples containing chol) were more stable in the
presence of chol than ordered domains in the absence of chol
(Fig. 2B and Table 1). This is in agreement with previous
studies showing that chol stabilizes ordered domain formation
[16,18,32,35–37]. However, rafts were not stabilized by chol in
samples containing C12:0- and C16:0-ceramide. This can beexplained by the observations that: (a) these ceramides prevent
strong association of chol with rafts (see below), and (b) the
chol that does associate with rafts partially displaces ceramide
from the rafts [19]. Thus, this result suggests that any tendency
of the chol that can associate with ceramide-rich rafts to increase
raft stability is insufficient to compensate for the loss of raft
stability because of partial displacement of ceramide from rafts
by chol.
The order of the effect of ceramide N-acyl chain length on
raft stability in the presence of chol is similar to that found in the
absence of chol (Table 1). Again, the C2:0-, C6:0-, and C8:0-
ceramides decreased ordered domain stability relative to that in
samples lacking ceramide, whereas C16:0-ceramide increased
ordered domain stability relative to that in the absence of
ceramide (Fig. 2B and Table 1). However, unlike the situation in
the absence of chol, C12:0-ceramide did not stabilize raft
formation relative to that in the absence of ceramide. This
implies that the increase in raft stability from raft-association by
C12:0-ceramide does not exceed the loss in raft stability from
displacement of chol by C12:0-ceramide (see below).
3.2. Raft-stabilizing abilities of ceramide analogues
The effect of a series of ceramide analogues on the stability
of rafts was also studied. We tested analogues of C12:0- and
C16:0-ceramide because, as shown above, the presence of a
long N-acyl chain is required to maintain stable ordered
domains. The Tempo quenching assay was first used to analyze
the raft-stabilizing abilities of several C12:0-ceramide analo-
gues in vesicles composed of 19.5:18:37.5:25 (mol:mol) SM:
ceramide:DOPC:chol (Fig. 3 and Table 2).
Vesicles containing an analogue with a C3-methyl group in
the sphingoid base (compound 1) had a similar raft stability as
C12:0-ceramide (compare Tables 1 and 2). We also observed
similar Tm values for the stereoisomer of compound 1, with
an inverted configuration at C3 (data not shown). In contrast,
relative to C12:0 ceramide, an analogue with a cyclopropyl
group bridging C4 and C5 somewhat stabilized raft formation
(compound 5), while an analogue with a combination of
a C3-methyl and a 4,5 cis double bond destabilized raft for-
mation slightly (compound 3). Raft stability in the presence of
analogues containing a replacement of the primary hydroxyl
group with a relatively bulky dimethyl-1,3-dioxanyl group
(compound 6), or containing a C3 methyl and a 4,5 single bond
(compound 2) or 4,5 triple bond (compound 4) seemed to differ
only slightly from that in the presence of C12:0 ceramide.
Raft stability was also assessed for a series of analogues of
C16:0-ceramide (compounds 7–11). As shown in Fig. 4 and
Table 2, raft stability in the presence of compound 7 was some-
what less, and in the presence of compounds 8–10 was at most
slightly less, than that in the presence of C16:0-ceramide (com-
pare Tables 2 and 1). The most striking result was a large
increase in raft stability, relative to that in the presence of C16:0
ceramide, observed in vesicles containing phytoceramide (com-
pound 11) (see Fig. 4). Also notice that, as for the parental
C16:0 and C12:0 ceramides, the mixtures with C16:0 analogues
all give higher Tm than those with the C12:0 analogues.
Table 2
Tm (melting temperature) of ordered domains in vesicles containing ceramide
analogues and 25 mol% cholesterol
Ceramide analogue Tm (°C)
C12:0 compounds
1 32.4±0.1
2 [34.5–38.4]
3 28.4±0.4
4 [29.2–36.7]
5 40.2±0.3
6 [28.0–33.6]
C16:0 compounds
7 40.6±0.3
8 43.2±0.2
9 [42.4–50.2]
10 42.8±0.2
11 [54.0–63.2]
Lipid compositions as given in Figs. 3 and 4. Data analyzed as described in
Table 1. In the cases in which a Tm range is shown for the C12:0 analogues,
melting curves were too incomplete to give a sigmoidal fit with a physically
meaningful limiting quenching value (i.e. F/Fob1) at low temperature, and
were analyzed as described in Table 1. In the cases in which a Tm range is shown
for the C16:0 analogues, melting curves were too incomplete to give a sigmoidal
fit with a physically meaningful limiting quenching value (i.e. F/FoN0) at high
temperature, and were analyzed as described in Table 1. In this case the Tm
range shown (in brackets) is for the maximum and minimum possible high
temperature limiting F/Fo values. The maximum limiting F/Fo value is 0, and
the minimum F/Fo value is the experimental value at the highest temperature
measured.
Fig. 4. Effect of analogues of C16:0-ceramide on raft stability as assessed from
the effect of temperature on quenching of Lc-TMADPHby Tempo. Vesicles were
composed of 19.5:18:37.5:25 SM:ceramide analogue:DOPC:chol. Key: com-
pound 7 (plus sign), compound 8 (triangle), compound 9 (open circle), com-
pound 10 (square), compound 11 (inverted triangle) and C16:0 ceramide (filled
circle). Quenching curves for compounds 9 and 11were assigned a limiting F/Fo
value of 0.3 at high temperature. Results shown are the average values from
duplicates.
Fig. 3. Effect of analogues of C12:0-ceramide on raft stability as assessed from
the effect of temperature on quenching of Lc-TMADPHbyTempo. Vesicles were
composed of 19.5:18:37.5:25 SM:ceramide analogue:DOPC:chol. Key: Panel A:
compound 1 (plus sign), compound 2 (open triangle), compound 3 (open circle)
and C12:0 ceramide (filled circle); Panel B: compound 4 (open triangle), com-
pound 5 (open circle), compound 6 (plus sign), and C12:0 ceramide (filled
circle). Results shown are the average values from duplicates.
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ceramide analogues
We previously found that ceramide is able to displace sterols
from rafts [19] and sought to determine whether ceramide
structure would affect displacement. For this study, we exa-
mined the displacement of the fluorescent sterol dehydroergos-
terol (DHE) from rafts as measured by a different fluorescent
quenching assay. This assay detects the displacement of DHE
from ordered domains by the fact that the displaced DHE moves
into disordered domains enriched in the nitroxide-labeled quen-
cher lipid 12SLPC [19]. Thus, ceramide-induced displacement
results in an increase in quenching (decrease in F/Fo) in the
presence of the ceramide. A decrease in F/Fo of 50% very
roughly corresponds to almost complete displacement of sterolfrom the ordered domains [19]. As shown in Fig. 5A and B,
both C12:0- and C16:0-ceramide derivatives have the ability to
strongly displace DHE from ordered domains. There was no
significant difference in sterol displacement tendency with the
Fig. 5. Displacement of dehydroergosterol (DHE) by various ceramide ana-
logues: (A) C12:0-ceramide and its analogues. (B) C16:0-ceramide and its
analogues. Samples containing ceramide or ceramide analogues were composed
of 19.5:18:37.5:12.5:12.5 DPPC:ceramide:12-SLPC:DHE:chol (F samples) or
the same mixture with DOPC in place of 12-SLPC (Fo samples). Samples
without ceramide were composed of 37.5:37.5:12.5:12.5 DPPC:12-SLPC:DHE:
chol (F samples) or the same mixture with DOPC in place of 12-SLPC (Fo
samples). Average values and the range from duplicate samples are shown.
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analogue concentration used.
4. Discussion
4.1. Structural features of ceramide that influence raft stability
This study shows that raft stability is related to ceramide N-
acyl chain length. A minimum of a C12:0 N-acyl chain length
was required for significant raft stability. It is known that
phospholipids with one long and one short acyl chain have low
Tm values, indicative of the inability to form thermally stable
ordered domains [38]. Because the alkyl group of the sphingoid
base of ceramide is equivalent to a long hydrocarbon chain,
short-chain ceramides are analogous to lipids with one long
chain. Thus, the inability of short-chain ceramides to stabilize
ordered domains formation is not surprising. The conclusion
that N-acyl chain structure is important for the ability of
ceramides to form thermally stable ordered domains is further
supported by our previous observation that N-oleoylsphingo-
sine disrupts ceramide's raft-stabilizing ability [19,39].Our observations with the short-chain ceramides in choles-
terol-containing vesicles are in close agreement with the very
recent study of Nybond et al. [40], who measured raft stability
by measuring the quenching of a sphingomyelin containing a
fluorescent parinaroyl fatty acyl chain by a nitroxide acyl chain-
labeled PC. One difference involves C2:0-ceramide. Both
studies concluded that C2:0-ceramide is less raft-destabilizing
than C6:0- and C8:0-ceramide; however, Nybond et al. found
C2:0-ceramide to be raft-stabilizing, while we found it to be
raft-destabilizing. The difference in the two studies could be
related to differences in the acyl chain structure of the lipid used
(POPC and C16:0-SM in Nybond et al. [40] vs. DOPC and
brain SM in our experiments) and/or to differences in the lipid
composition (10 mol% chol and a higher PC content in Nybond
et al. [40] vs. 25 mol% chol and a lower PC content in our
experiments).
It should also be noted that the absolute values of Tm could
be affected by a number of factors. For example, vesicle size can
affect Tm slightly [41], as can the partition coefficient of the
fluorescent probe between fluid and ordered domains. In this
study we used LcTMADPH, which partitions favorably into
ordered domains [42], because unlike DPH which partitions
more equally between ordered and disordered domains, LcTM-
ADPH is not displaced from ceramide-rich ordered domains
[19]. The use of LcTMADPH gives Tm values a couple of
degrees higher than does DPH, but this does not affect relative
Tm values significantly [31].
Our studies also show that the effects of ceramide N-acyl
chain length on ordered domain stability are qualitatively simi-
lar in the absence and presence of chol. This indicates that the
effect of N-acyl chain length on tight lipid packing is crucial to
the ability of ceramide to stabilize rafts, and that the ability of
ceramide to stabilize rafts does not involve a specific ceramide-
sterol interaction.
The behavior of C12:0- and C16-ceramide analogues
reveals that most small modifications near the polar headgroup
of the sphingoid base do not strongly influence raft-stabilizing
ability nearly as much as changes in acyl chain length. The
observation that the physical behavior of these analogues is
similar to that of natural ceramides is confirmed by
measurements of ceramide-induced displacement of sterol
from rafts. We previously demonstrated that ceramide and chol
compete to be accommodated in rafts, and that ceramide,
which is preferentially accommodated, displaces sterols from
the rafts [19]. Fig. 5 shows that displacement of DHE from
rafts by ceramide analogues with a modified sphingoid base is
very similar to that for C16:0-ceramide. It is interesting that
the dipole potentials of monolayers containing the C16:0-
ceramide analogues have been previously found to be quite
dependent on ceramide analogue structure [24]. Thus, our
results indicate that dipole potential does not strongly
influence raft formation.
The observation that small changes in ceramide structure do
not greatly change the ability to stabilize rafts (with the exception
of C16:0-D-ribophytoceramide, which stabilized rafts to a
significantly greater degree than C16:0-ceramide), or disrupt the
ability to displace chol from rafts is somewhat surprising because
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stability is sensitive to small perturbations in sterol structure
[18,32,37]. It may be that changes in the ability of lipids to pack
tightly is more sensitive to small changes in the molecular
structure of their hydrophobic segments than small changes in
their polar headgroups. This would be consistent with the
observation that ceramide acyl chain length had a larger effect on
ordered domain Tm than changes in ceramide headgroup
structure. In most cases in which lipid headgroup structure is
small, it may be possible for the lipid headgroup to adjust con-
formation to avoid interfering with lipid packing. The large
ordered domain-stabilizing effect of phytoceramide may reflect
additional hydrogen bonding capability.
The fact that long-chain ceramide analogues which are likely
to resist normal metabolic breakdown pathways can have raft
formation properties similar to those of natural ceramides sug-
gests that they may have useful applications in cellular and
biomedical studies. C12:0-ceramide analogues may be the best
for such applications if they can be delivered into cells more
easily than longer chain analogues (see below).
4.2. Use of short-chain vs. long-chain ceramide to study
biological activity
Since the identification of ceramide as a lipid second mes-
senger, numerous investigators have employed ceramide analo-
gues to study the biological roles of ceramide [43–49]. Short-
chain ceramides are frequently used because they are taken up
into cells more easily than long-chain ceramides. However, our
study and that of Nybond et al. [40] show that short-chain
ceramides cannot support lipid raft formation as well as long-
chain ceramides. This might alter the effects of short-chain
ceramide analogues on some cellular processes. In fact, in rat
basophilic leukemia cells, C2:0- and C6:0-ceramides have been
reported to disrupt membrane order [50], consistent with raft-
destabilizing behavior.
Thus, it is not surprising that there are differences in the
biological actions of short- and long-chain ceramides. For
example, the effects of ceramide on apoptosis have been
extensively investigated. Short-chain ceramides induce apop-
tosis in several cancer cell lines [51–53], while longer-chain
natural length ceramides are much less effective [54]. This
difference may partly be an artifact of the difficulty of
delivering long chain ceramides into cells [54]. However,
while natural ceramides form large ceramide-rich raft plat-
forms that are indispensable in Fas ligand-mediated apoptosis
[13], short chain ceramides should not have this ability. This
suggests that ceramide participates in more than one aspect of
the apoptotic process. One way it may act is as a molecule that
directly interacts and modulates the activity of proteins in the
apoptotic signaling pathway. Forming ordered domains that act
as signaling platforms to cluster membrane proteins involved
in apoptosis may reflect a separate aspect of ceramide action.
In addition, it is interesting to note that C2:0-ceramide, but not
C16:0-ceramide, was able to cause loss of membrane potential
in isolated mitochondria, suggesting that these short chain and
long chain ceramides may accumulate in different locations[55]. It should also be noted that comparing studies in which
chemical properties of ceramides were varied are complicated
by differences in the experimental time scale, which can range
from minutes to days. In some cases, direct actions of ceramide
may be involved, while in other cases metabolites of ceramide
may be involved, e.g. remodeling of short-chain ceramides to
long-chain ceramides within cells. In any case, C12:0-
ceramide and its derivatives may be useful for studies of
ceramide action as they maintain the essential raft-stabilizing
properties of natural ceramides, and might be easier to
incorporate into cells than longer chain ceramides in some
situations [54].
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